Hisamitsu Pharmaceutical ...

PNK: HTSUF · Real-Time Price · USD
32.30
0.00 (0.00%)
At close: Apr 28, 2025, 9:30 AM

Company Description

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan.

The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies.

It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders.

In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch.

Further, it provides HFT-290, a transdermal patch for cancer pain.

The company sells its products in the United States and Asia.

Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Hisamitsu Pharmaceutical Co. Inc.
Hisamitsu Pharmaceutical Co. Inc. logo
Country JP
IPO Date Sep 23, 2010
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,759
CEO Kazuhide Nakatomi

Contact Details

Address:
408, Tashiro Daikan-machi
Tosu,
JP
Website https://www.hisamitsu.co.jp

Stock Details

Ticker Symbol HTSUF
Exchange PNK
Fiscal Year March - February
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number JP3784600003
Employer ID -
SIC Code n/a

Key Executives

Name Position
Kazuhide Nakatomi President, Chief Executive Officer & Director
Koji Takiyama Executive Officer, GM of President's Office, Digital Transformation Officer & Director
Kosuke Sugiyama Executive MD of Human Resources, Research & Development, Corporate Planning and Director
Kyu Saito MD, Executive Officer, GM of Global Business & Director
Masaya Okuno Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Division
Mitsutoshi Tsuruta Senior Executive Officer & GM of Pharmaceutical Business Division
Naruhito Higo Executive Vice President & Head of Global Technology
Nobuo Tsutsumi Exe Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director
Shinichi Murayama Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director
Tetsuo Akiyama Senior Managing Executive Officer, Head of Business Operations & Head of BU

Latest SEC Filings

No SEC filings available.